Business
Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off
Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off.
About this update from Endonovo Therapeutics, Inc.
[{"type":"text","content":"\n Los Angeles, CA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the retention of Ocean Tomo, a part of J.S. Held, to conduct a fairness opinion analysis in connection with the proposed spin-off of Endonovo’s medical device assets to a newly formed Delaware company, SofPulse, Inc. Endonovo’s SofPulse® medical device offers patients and healthcare providers significant benefits including a viable treatment solution for post-surgical pain, edema and edema reduction that works with effectiveness, convenience, innovation and quality. All products are supported with quality customer service. Expert Opinion “We are pleased to be engaged by Endonovo and look forward to working to provide the board with our assessment and conclusions,” said Ocean Tomo Managing Director Greg Campanella. Ocean Tomo, a part of J.S. Held, is a leading provider of expert opinion, management consulting and advisory services focused on intellectual property (IP) and other intangible assets. Ocean Tomo has been retained to provide Endonovo with its opinion as to the fairness of the current Fair Market Value (FMV) and purchase price of Endonovo’s medical device operating segment. The fairness opinion will be prepared for Endonovo and referenced in filings with the Securities and Exchange Commission (SEC). It will evaluate the fairness of the terms of the proposed spin-off from a financial point of view. Assessment for Shareholders Ocean Tomo, a part of J.S. Held, is a respected management consulting and financial services firm with deep expertise in the valuation of intellectual property, litigation and engineering. The firm has a proven track record of providing objective assessments of the fairness of transactions and has completed more than 1,000 engagements, including over 300 valuation and 500 financial damages expert testimony engagements. Ocean Tomo’s analysis is expected to be completed in the first quarter of 2023. Once the proposed spin-off is fully structured and the necessary agreements are completed, Endonovo will prepare the appropriate filings with the SEC and provide information to shareholders. Ocean Tomo’s Record Ocean Tomo, a part of J.S. Held, has provided hundreds of objective assessments of the fairness of transactions. As a part of J.S. Held, Ocea...